Peptide Lv and Angiogenesis: A Newly Discovered Angiogenic Peptide
2024
Peptide Lv and Angiogenesis: A Newly Discovered Angiogenic Peptide
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Pham Dylan L., Cox Kelsey, Ko Michael L., Ko Gladys Y.-P.
Primary Institution: Texas A&M University
Hypothesis
Is peptide Lv an angiogenic factor?
Conclusion
Peptide Lv promotes angiogenesis and has potential therapeutic implications for diseases involving pathological neovascularization.
Supporting Evidence
- Peptide Lv binds to VEGFR2 and promotes angiogenesis.
- Peptide Lv increases endothelial cell proliferation and migration.
- Peptide Lv is upregulated in patients with diabetic retinopathy.
Takeaway
Peptide Lv is a small protein that helps blood vessels grow, which is important for healing but can also cause problems in diseases like diabetes.
Methodology
The study involved in vitro assays with human umbilical vein endothelial cells and in vivo assays using chicken chorioallantoic membrane and mouse models.
Limitations
The study primarily focuses on in vitro and animal models, which may not fully represent human conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website